324 related articles for article (PubMed ID: 12087562)
1. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
[TBL] [Abstract][Full Text] [Related]
2. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of repeated administration of calcium disodium ethylenediaminetetraacetate during excessive exposure to lead in rats.
Goyer RA; Cherian MG; Delaquerriere-Richardson L
J Environ Pathol Toxicol; 1978; 1(4):403-10. PubMed ID: 102714
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities.
Sivaprasad TR; Malarkodi SP; Varalakshmi P
Chem Biol Interact; 2004 Apr; 147(3):259-71. PubMed ID: 15135082
[TBL] [Abstract][Full Text] [Related]
5. ["Terzo fuoco", lead poisoning and chronic renal failure].
Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Mar; 470():1-330. PubMed ID: 12579203
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of initial results of treatment of lead poisoning with EDTA].
Petkova V; Adjarov D; Pavlova S; Naydenova E; Kerimova M; Kuneva T
Med Lav; 1994; 85(4):299-308. PubMed ID: 7808345
[TBL] [Abstract][Full Text] [Related]
9. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
Lin JL; Lin-Tan DT; Hsu KH; Yu CC
N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
[TBL] [Abstract][Full Text] [Related]
10. Failure of chelation therapy in lead nephropathy.
Germain MJ; Braden GL; Fitzgibbons JP
Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141
[TBL] [Abstract][Full Text] [Related]
11. [Chronic nephropathy in saturnism. Comparative elimination of lead by classic chelating agents and peritoneal dialysis].
Mirouze J; Mion C; Mathieu-Daude P; Monnier L; Selam JL
Nouv Presse Med; 1975 May; 4(22):1642-4. PubMed ID: 1215179
[TBL] [Abstract][Full Text] [Related]
12. Lead-induced oxidative stress and hematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats.
Saxena G; Flora SJ
J Biochem Mol Toxicol; 2004; 18(4):221-33. PubMed ID: 15452883
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
14. Influence of methionine supplementation in chelation of lead in rats.
Kachru DN; Khandelwal S; Tandon SK
Biomed Environ Sci; 1989 Sep; 2(3):265-70. PubMed ID: 2514724
[TBL] [Abstract][Full Text] [Related]
15. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy.
Cory-Slechta DA; Weiss B; Cox C
J Pharmacol Exp Ther; 1987 Dec; 243(3):804-13. PubMed ID: 3121845
[TBL] [Abstract][Full Text] [Related]
16. Chronic lead poisoning: a "forgotten" cause of renal disease.
Benjelloun M; Tarrass F; Hachim K; Medkouri G; Benghanem MG; Ramdani B
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):83-6. PubMed ID: 17237897
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
[TBL] [Abstract][Full Text] [Related]
18. Occult lead intoxication in patients with gout and kidney disease.
Wright LF; Saylor RP; Cecere FA
J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
[TBL] [Abstract][Full Text] [Related]
19. The Mongolian gerbil as a model for lead toxicity. I. Studies of acute poisoning.
Port CD; Baxter DW; Richter WR
Am J Pathol; 1974 Jul; 76(1):79-94. PubMed ID: 4366850
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
